All of a sudden, Amgen stock is up 15% since late December to around $299. Its rise helped push up the healthcare sector up ...

Earnings season is in full swing in the pharma sector with major players sharing their latest results. On Tuesday (February 4 ...

Earnings season continues, with a diverse array of companies set to unveil their financial results for the next trading day. Investors are gearing up for a busy Tuesday as tech giants, pharmaceutical ...

Amazon and Google parent Alphabet are set to report earnings, along with other tech companies including AI darling Palantir, and chipmaker Advanced Micro Devices. Pharmaceutical firms Novo Nordisk, ...

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

Below we have compiled a full list of Google algorithm launches, updates, and refreshes that have rolled out over the years, as well as links to resources for SEO professionals who want to ...

Datapharm has announced its expansion into the United States through a new partnership with phactMI. The collaboration aims to improve the quality and accessibility of medicines information for ...

In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against other best cheap stocks to buy for 2025. The U.S. consumer prices report released this week revealed a ...

Jefferies analyst Michael Yee maintained a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $350.00. The company’s shares closed yesterday at $267.10. Discover ...

JPM25 is in full swing as several pharma powerhouses—including Merck, Lilly and Amgen—detail their strategies for growth in the coming year. After an explosive opening marked by a suite of ...